Skip to main content

Table 3 HUNT 3: Characteristics of participants in the MRI study (MRI-p), non-participants (MRI-np) and non-invited (MRI-ni)

From: Does health differ between participants and non-participants in the MRI-HUNT study, a population based neuroimaging study? The Nord-Trøndelag health studies 1984–2009

VARIABLES

WOMEN

MEN

 

MRI-p

MRI-np

MRI-ni

p

MRI-p

MRI-np

MRI-ni

p

Demographic

(n = 530)

(n = 286)

(n = 6678)

 

(n = 476)

(n = 268)

(n = 5695)

 

Age (mean [SD])

57.6 [4.2]

57.6 [4.3]

58.2 [4.5]

<0.0012

57.9 [4.1]

57.7 [4.2]

58.3 [4.5]

0.0271

Education >12 years (n [%])

179 [34.0]

94 [33.2]

1349 [20.1]

<0.0012

156 [32.9]

79 [29.8]

1292 [22.9]

<0.0012

Separated or divorced (n [%])

86 [16.2]

42 [14.7]

881 [13.0]

0.0852

56 [11.8]

41 [15.3]

619 [10.6]

0.0712

Non-employed (n [%])

101 [19.3]

79 [27.9]

1889 [28.1]

<0.0012

76 [16.0]

42 [15.7]

1233 [21.7]

0.0012

Health-related

        

Fair or poor health (n [%])

164 [31.7]

100 [35.8]

2097 [32.2]

0.4182

110 [23.4]

70 [26.6]

1459 [26.3]

0.3892

Physical inactivity (n [%])

11 [2.1]

10 [3.5]

184 [2.8]

0.4732

18 [3.8]

11 [4.1]

283 [5.0]

0.4072

Daily smoking (n [%])

92 [17.4]

60 [21.0]

1661 [24.5]

0.0012

70 [14.7]

57 [21.3]

1046 [18.4]

0.0582

Alcohol abstainers(n [%])

18 [3.4]

14 [4.9]

263 [4.0]

0.5792

9 [1.9]

5 [1.9]

123 [2.2]

0.8732

BMI (mean [SD])

26.6 [4.1]

27.8 [4.9]

27.5 [4.6]

<0.0011

27.3 [3.1]

27.9 [3.9]

27.9 [3.6]

0.0031

BMI ≥30 kg/m2 (n [%])

110 [20.8]

79 [27.6]

1761 [26.0]

0.0222

93 [19.5]

69 [25.7]

1413 [24.9]

0.0302

Headache(n [%])

192 [42.5]

79 [36.1]

2177 [38.2]

0.1552

120 [29.1]

60 [29.4]

1298 [27.9]

0.7922

Musculoskeletal pain(n [%])

286 [63.4]

141 [64.7]

3576 [62.3]

0.7182

200 [47.8]

108 [52.4]

2351 [50.4]

0.4932

HADS A score(mean [SD])

4.0 [3.5]

4.5 [3.5]

4.3 [3.5]

0.1581

3.2 [2.8]

3.6 [3.1]

3.5 [3.1]

0.2541

HADS D score(mean [SD])

2.9 [2.6]

3.0 [2.6]

3.3 [2.9]

0.0021

3.4 [2.9]

3.7 [2.9]

3.7 [2.9]

0.2431

Antihypertensive use (n [%])

101 [19.1]

54 [18.9]

1638 [24.2]

0.0052

93 [19.5]

60 [22.4]

1495 [26.3]

0.0032

Laboratory measurements

        

SBP (mean [SD])

129.7 [17.1]

132.0 [19.3]

132.2 [18.7]

0.0061

134.2 [16.5]

136.0 [17.8]

135.4 [17.0]

0.2771

SBP ≥140 mmHg (n [%])

136 [25.8]

100 [35.7]

1880 [32.2]

0.0042

165 [35.2]

96 [36.1]

1805 [36.7]

0.7922

DBP (mean [SD])

73.2 [10.5]

74.1 [10.9]

73.5 [10.5]

0.4851

79.9 [9.9]

80.9 [10.0]

79.9 [10.2]

0.2781

DBP ≥90 mmHg (n [%])

34 [6.4]

21 [7.5]

387 [6.6]

0.8302

71 [15.1]

43 [16.2]

798 [16.2]

0.8162

Cholesterol (mean [SD])

5.9 [1.1]

5.8 [1.1]

6.0 [1.1]

0.0551

5.5 [1.0]

5.4 [1.0]

5.6 [1.0]

0.0011

High cholesterol (n [%])

149 [30.1]

79 [30.0]

2120 [31.9]

0.5892

75 [16.5]

33 [13.3]

1152 [20.5]

0.0032

HDL Cholesterol(mean [SD])

1.5 [0.4]

1.5 [0.4]

1.5 [0.4]

0.3641

1.2 [0.3]

1.2 [0.3]

1.2 [0.3]

0.1031

Triglycerides (mean [SD])

1.5 [0.8]

1.6 [0.9]

1.6 [0.9]

0.1341

1.8 [1.0]

1.9 [1.2]

1.9 [1.2]

0.0551

Glucose (mean [SD])

5.4 [1.5]

5.6 [1.4]

5.6 [1.4]

0.0181

5.8 [1.8]

5.7 [1.6]

6.0 [1.8]

0.0391

Glucose ≥5.6 mmol/l (n [%])

76 [15.4]

48 [18.3]

1387 [20.9]

0.0092

125 [27.5]

60 [24.1]

1763 [31.3]

0.0162

  1. 1. One-way analysis-of-variance 2. Chi-squared test.
  2. BMI: Body mass index; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; Fair or poor health: Fair or poor self-perceived health; Antihypertensive use: Current use of antihypertensive medication; Glucose: Non-fasting glucose; High Cholesterol: Cholesterol ≥6.6 mmol/l.